Steroid-induced mental disorders in cancer patients: a systematic review
dc.contributor.author | Ismail, Muhammad Fahmi | |
dc.contributor.author | Lavelle, Clianna | |
dc.contributor.author | Cassidy, Eugene M. | |
dc.date.accessioned | 2018-12-06T10:17:29Z | |
dc.date.available | 2018-12-06T10:17:29Z | |
dc.date.issued | 2017-11-30 | |
dc.description.abstract | Corticosteroids are a central part of many cancer treatment regimens. Neuropsychiatric toxicity has complicated their use, including an association with a spectrum of symptoms, from insomnia, cognitive impairment and mood symptoms, to severe mental disorders, including mania, psychosis and severe depression. Although steroid-induced mental disorders were first reported in medicine more than 60 years ago, there is a dearth of evidence available to date on optimal treatment and prevention to guide cancer clinicians. We completed a systematic review of the current evidence for therapeutic and prophylactic interventions of steroid-induced mental disorders in cancer. We searched Medline, Embase and PsycINFO and selected studies related to steroid-induced mental disorder. The studies found were limited to case series and case reports only. | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Accepted Version | en |
dc.format.mimetype | application/pdf | en |
dc.identifier.citation | Ismail, M. F., Lavelle, C. and Cassidy, E. M. (2017) 'Steroid-induced mental disorders in cancer patients: a systematic review', Future Oncology, 13(29), pp. 2719-2731. doi: 10.2217/fon-2017-0306 | en |
dc.identifier.doi | 10.2217/fon-2017-0306 | |
dc.identifier.endpage | 2731 | en |
dc.identifier.issn | 1479-6694 | |
dc.identifier.issn | 1744-8301 | |
dc.identifier.issued | 29 | en |
dc.identifier.journaltitle | Future Oncology | en |
dc.identifier.startpage | 2719 | en |
dc.identifier.uri | https://hdl.handle.net/10468/7176 | |
dc.identifier.volume | 13 | en |
dc.language.iso | en | en |
dc.publisher | Future Medicine | en |
dc.relation.uri | https://www.futuremedicine.com/doi/abs/10.2217/fon-2017-0306 | |
dc.rights | © 2017 Future Medicine. This is the Author’s Accepted Manuscript of a work published in Future Oncology. The version of record is available at https://www.futuremedicine.com/doi/abs/10.2217/fon-2017-0306 | en |
dc.subject | Corticosteroids | en |
dc.subject | Dexamethasone | en |
dc.subject | Glucocorticoids | en |
dc.subject | Hypomania | en |
dc.subject | Mania | en |
dc.subject | Neuropsychiatric adverse effects | en |
dc.subject | Prednisolone | en |
dc.subject | Psychiatric disorder | en |
dc.subject | Psychosissteroid-induced mental disorder | en |
dc.title | Steroid-induced mental disorders in cancer patients: a systematic review | en |
dc.type | Article (peer-reviewed) | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- 7622_Accepted_manuscript_systematic_review_steroid.pdf
- Size:
- 568.75 KB
- Format:
- Adobe Portable Document Format
- Description:
- Accepted version
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 2.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: